Position in ANRO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$659,750
+$97,750 QoQ
Shares Held
25,000
0.0% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 114 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BROWN ADVISORY INC holds $215,063,921 across 28 Biotechnology names. ANRO ranks #15 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,287,558 | $90,965,971 | |
| 2 | CYTK |
Cytokinetics Inc
|
570,664 | $48,614,865 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
487,017 | $28,310,297 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
77,398 | $23,299,119 | |
| 5 | INSM |
INSMED Inc
|
41,694 | $4,445,414 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,562 | $3,756,271 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,274 | $3,288,549 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
35,881 | $2,808,405 |
All Filings in ANRO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $659,750 | 25,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $562,000 | 25,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $445,000 | 25,000 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $100,500 | 25,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $55,000 | 25,000 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $54,000 | 25,000 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $105,750 | 25,000 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||